A new vital brand
We proud to present a new brand identity and message platform for an exciting new Swedish biotech company. Annexin Pharamceutical aims to provide effective therapy for a broad range of cardiovascular diseases by harnessing the potential of the body’s own protein Annexin A5. Together with Annette Colin Lövgren and Anna Frostegård we developed a new brand identity. Thanks for this interesting challenge and a great cooperative project. We learnt a lot about the endogenous defense protein Annexin A5 and vascular diseases. I hope we helped you develop skills in how to create a strong brand that supports your business strategy and ultimately contributes to a successful future.